Dana‑Farber Breaks Ground on 300‑Bed Cancer Hospital, Shifting Alliance to Beth Israel Lahey
Tap title to read story
Dana‑Farber Cancer Institute broke ground Monday on a 300‑bed, 450,000‑square‑foot cancer hospital that will open in 2031 on the former Joslin Diabetes Center site on Brookline Avenue. The new facility will create about 2,400 jobs over the next four years and will feature a bridge to Beth Israel Deaconess Medical Center, replacing the existing bridge to Mass General Brigham. The move follows Dana‑Farber’s 2023 decision to end its long‑standing partnership with Mass General Brigham and begin a new collaboration with Beth Israel Lahey Health, the state’s second‑largest health system. Boston Mayor Michelle Wu called the groundbreaking “a significant moment in history.” Dana‑Farber will house hospitalized cancer patients at Beth Israel Deaconess until the new hospital opens, with a staged transition of patients and outpatient services beginning this week. The partnership shift is expected to be completed by 2028.
Timeline
- 2023 — Dana‑Farber ends partnership with Brigham, joins Beth Israel
- 2026 — Construction begins, expected to finish by end of two thousand
- On March 16 2026 Groundbreaking ceremony for new cancer hospital.
- 2030 — Construction scheduled to complete by end of two thousand thirty
- 2031 — Hospital opens, providing inpatient cancer care